Vasopressin-neurophysin II gene expression in the ovary: studies in Sprague–Dawley, Long–Evans and Brattleboro rats

in Journal of Endocrinology
Authors:
P. J. Fuller
Search for other papers by P. J. Fuller in
Current site
Google Scholar
PubMed
Close
,
J. A. Clements
Search for other papers by J. A. Clements in
Current site
Google Scholar
PubMed
Close
,
G. W. Tregear
Search for other papers by G. W. Tregear in
Current site
Google Scholar
PubMed
Close
,
I. Nikolaidis
Search for other papers by I. Nikolaidis in
Current site
Google Scholar
PubMed
Close
,
P. L. Whitfeld
Search for other papers by P. L. Whitfeld in
Current site
Google Scholar
PubMed
Close
, and
J. W. Funder
Search for other papers by J. W. Funder in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

The neurohypophysial hormones oxytocin and arginine vasopressin (AVP) have been identified on immunological criteria in the ovary. Confirmation of extraneuronal synthesis requires the demonstration in the tissue of the specific messenger RNA (mRNA) for the preprohormone. Using a synthetic pentadecamer nucleotide probe, highly specific for the 5′ region of rat neurophysin II (NPII), we have demonstrated the presence of AVP-NPII mRNA in the ovary of Sprague–Dawley, Long–Evans and Brattleboro rats, with an apparent molecular weight identical to that seen for hypothalamus. These findings, together with the presence of immunoreactive AVP in the ovaries but not hypothalami of Brattleboro rats, suggest that tissue-specific differences in AVP-NP II gene expression occur at the translational as well as transcriptional level.

J. Endocr. (1985) 105, 317–321

 

  • Collapse
  • Expand